Stay updated on Study CB-839 + Paclitaxel in TNBC: Clinical Trial
Sign up to get notified when there's something new on the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page.

Latest updates to the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded location sections for 17 sites across Alabama, Connecticut, District of Columbia, Florida, Georgia, Louisiana, Maryland, Michigan, Missouri, New Jersey, New York, Pennsylvania, South Carolina, Tennessee, Texas, Washington, and Wisconsin. Also updated the page revision to v3.3.3.SummaryDifference2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now shows a revision label 'Revision: v3.3.2' replacing the previous 'Revision: v3.3.1'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page shows a minor revision history update: the new revision v3.3.1 was added and v3.2.0 was removed; no study content or interface changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedRemoved the site-wide notice about government funding and NIH operating status from the page, and the study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check63 days agoChange DetectedNo substantive changes to the study details are detected; the screenshots show only minor formatting and layout differences without affecting core information such as status, eligibility, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check92 days agoChange DetectedAdded a government-status notice and updated version to v3.2.0; removed reference to v3.1.0.SummaryDifference3%

Stay in the know with updates to Study CB-839 + Paclitaxel in TNBC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page.